TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
VERA

Vera Therapeutics Inc

Healthcare · Biotechnology

33.30$ +0.9% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow VERA
Line item 2019 2020 2021 2022 2023 2024 2025
– – – – – – –
– -50.7% -29.9% -580.7% – – +345.7%
– +25.9% +810.0% +195.1% +29.3% +81.0% +82.3%
– +3,271.7% -103.7% – – – –
– -76.2% +2,754.5% +92.2% -187.0% – +764.4%
– -20.8% -100.0% – +1.6% +1,442.9% -35.2%
– -66.4% +9,909.5% +1,578.2% -44.1% +977.9% –
– – – -95.7% -100.0% – -100.0%
– – -10.1% +302.7% +24.9% -100.0% –
– – -36.8% +89.2% +31.0% +354.3% -49.1%
– – -48.5% -239.4% – +2,334.7% +458.0%
– – – – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?